Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 15;125(18):3131-3138.
doi: 10.1002/cncr.32198. Epub 2019 May 23.

Breast cancer histologic subtypes show excess familial clustering

Affiliations

Breast cancer histologic subtypes show excess familial clustering

N Lynn Henry et al. Cancer. .

Abstract

Background: The inherited predisposition to developing specific histologic subtypes of invasive breast carcinoma has been incompletely investigated. By using a large, population-based database, the authors sought to investigate familial clustering of breast cancer by histologic subtype.

Methods: By using the Utah Population Database, which links genealogy records to the National Cancer Institute's statewide Surveillance, Epidemiology, and End Results cancer registry, the authors identified patients with breast cancer by histology and tested for evidence of shared genetic predisposition to histologic specific subtypes by examining pairwise relatedness and estimating the relative risk (RR) among first-degree, second-degree, and third-degree relatives.

Results: The authors identified 23,629 individuals in the Utah Population Database who had at least 3 generations of genealogy and at least 1 primary breast cancer, 2883 (12.2%) of which were specific histologic subtypes other than invasive ductal carcinoma (including inflammatory [n = 178], lobular [n = 1688], and mucinous [n = 542]). Statistically significant excess distant relatedness was identified for the mucinous subtype (P = .011) as well as for inflammatory breast cancers (P = .024). The RR for breast cancer of any histology in second-degree relatives was significantly increased for patients with inflammatory (RR, 1.32; 95% CI, 1.02-1.68; P = .03), lobular (RR, 1.36; 95% CI, 1.25-1.47; P < .001), and mucinous (RR, 1.27; 95% CI, 1.12-1.44; P = .00021) subtypes.

Conclusions: These findings provide evidence for significant familial clustering within histological subtypes for lobular, mucinous, and inflammatory breast carcinomas. Further research is required to identify the underlying genetic variants responsible for the increased risk. Studies of high-risk pedigrees segregating a specific histologic subtype could be a powerful design for predisposition gene identification.

Keywords: Utah Population Database (UPDB); breast cancer; familiality; inflammatory; lobular; mucinous.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Neither author reports relevant conflicts of interests. NLH reports funding to her institution for the conduct of pharmaceutical-sponsored clinical trials by AstraZeneca, AbbVie, H3 Biosciences, Innocrin Pharmaceuticals, and Pfizer.

Figures

Figure 1.
Figure 1.. Example of a high-risk mucinous breast cancer pedigree from the Utah Population DataBase.
Females are designated by circles and males by squares. Individuals with mucinous breast cancer are designated by a solid symbol. Deceased individuals are shown with a hash-mark through the symbol.

References

    1. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer. 2000;88: 2887. - PubMed
    1. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. . Lyon, France: IARC Press, 2003.
    1. Nguyen B, Veys I, Leduc S, et al. Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer. J Natl Cancer Inst. 2019. - PubMed
    1. Kehr EL, Jorns JM, Ang D, et al. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. Hum Pathol. 2012;43: 2207–2212. - PubMed
    1. Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. 2011;22: 515–523. - PMC - PubMed

MeSH terms